Safety of adjuvanted pandemic influenza vaccines: background rate of narcolepsy in Europe
Reference:
Dieleman, J., Lecomte, C., Schuemie, M., van Rolleghem, A., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Jokinen, J., Nohynek, H., Kilpi, T., Storsaeter, J., van der Maas, N., Heijbel, H., Arnheim-Dahlstrom, L., Sparen, P., Sammon, C., De Vries, C., Plazzi, G., Menna, A., Trotta, F., Santuccio, C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M., 2011. Safety of adjuvanted pandemic influenza vaccines: background rate of narcolepsy in Europe. Pharmacoepidemiology and Drug Safety, 20 (Supplement 1), S260.
Related documents:
This repository does not currently have the full-text of this item.You may be able to access a copy if URLs are provided below. (Contact Author)
Official URL:
http://dx.doi.org/10.1002/pds.2206
Details
| Item Type | Articles |
| Creators | Dieleman, J., Lecomte, C., Schuemie, M., van Rolleghem, A., Hviid, A., Svanstrom, H., Molgaard-Nielsen, D., Jokinen, J., Nohynek, H., Kilpi, T., Storsaeter, J., van der Maas, N., Heijbel, H., Arnheim-Dahlstrom, L., Sparen, P., Sammon, C., De Vries, C., Plazzi, G., Menna, A., Trotta, F., Santuccio, C., Johansen, K., Kramarz, P., Weibel, D., Bonhoeffer, J. and Sturkenboom, M. |
| DOI | 10.1002/pds.2206 |
| Departments | Faculty of Science > Pharmacy & Pharmacology |
| Refereed | No |
| Status | Published |
| ID Code | 26288 |
| Additional Information | Meeting abstract from the 27th International Conference on Pharmacoepidemiology & Therapeutic Risk ManagementHyatt Regency Chicago, Chicago, Illinois, USA, August 14–17, 2011. |
Export
Actions (login required)
| View Item |
